Clinical Trial Update: First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Plexium, Inc. is conducting a first-in-human Phase 1 study of PLX-61639 in locally advanced or metastatic solid tumors, and the trial is currently recruiting. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma
• Esophageal Squamous Cell Carcinoma
• Gastric Adenocarcinoma
• Gastric Squamous Cell Carcinoma
• Gastroesophageal Junction Adenocarcinoma
• Gastroesophageal Junction Squamous Cell Carcinoma
• Non-small Cell Lung Cancer
• Solid Tumor

Drugs mentioned

• PLX-61639 (PLX-61639)

Snippet

Sponsor: Plexium, Inc. | Conditions: Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma | Phase 1 | Status: RECRUITING